Phase 4 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose condition involves early-stage squamous cell cancer or high-grade abnormal cell growth (a pre-cancerous condition) located in the upper part of the food pipe (esophagus)
- People whose scans and internal camera examinations show no signs that the cancer or abnormal cells have spread to nearby lymph nodes or other parts of the body
- People who have been fully informed about the study and have agreed to take part by signing a consent form
Who may not be able to join:
- People who have already received radiation therapy or chemotherapy before the planned surgical procedure (a procedure called endoscopic submucosal dissection, where tissue is removed using a camera and instrument passed down the throat)
- People with serious other health conditions that would make the endoscopic submucosal dissection procedure unsuitable for them (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wei Liang, MD, Fujian Provintial Hospital
Phone: +86 13599382136
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the rate of complete resection and postoperative stricture
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.